PRME EBITDA Growth
Prime Medicine Inc · EBITDA Growth
PRME EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported6.21%period ending
PRME TTM EBITDA YoY % (-1781.42% → 6.21%)
Year-over-year change
High-resolution chart · PNG
PRME ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 6.2057% | |
| 2.4204% | |
| -2.1433% | |
| 6.0813% | |
| 4.619% | |
| -3.4718% | |
| -3.5193% | |
| -20.0971% | |
| -37.352% | |
| -40.0369% | |
| -52.0619% | |
| -17.703% | |
| -10.1489% | |
| -33.5453% | |
| -46.545% | |
| -508.7587% | |
| -1,781.4193% |